AI agents could shoulder 55% of biopharma work, Accenture study finds

AI agents are shaking up biopharma, but here’s the twist—Accenture and Wharton say they could automate 55 percent of workforce hours and unlock up to 240 billion dollars annually. Why does this matter to paper packaging? Because as biopharma slashes R&D cycles and operational costs, demand for faster, adaptive packaging—especially for clinical trials and personalized medicine—skyrockets. Think modular, just-in-time paper-based packaging systems. As lab robots evolve with AI agents, packaging lines must mirror that agility. So yes, AI may be biotech’s future—but it’s also the paper industry’s next big disruptor.https://www.drugdiscoverytrends.com/ai-agents-could-shoulder-55-of-biopharma-work-accenture-wharton-study-finds/

Comments

Popular posts from this blog

Coffee pods, bulky rigids may lose 'check locally' label

New DOJ proposal still calls for Google to divest Chrome, but allows for AI investments